165 related articles for article (PubMed ID: 29593568)
1. Bisecting N-Acetylglucosamine Structures Inhibit Hypoxia-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells.
Tan Z; Wang C; Li X; Guan F
Front Physiol; 2018; 9():210. PubMed ID: 29593568
[TBL] [Abstract][Full Text] [Related]
2. Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling.
Cheng L; Cao L; Wu Y; Xie W; Li J; Guan F; Tan Z
Front Oncol; 2020; 10():929. PubMed ID: 32612952
[TBL] [Abstract][Full Text] [Related]
3. Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions.
Pinho SS; Oliveira P; Cabral J; Carvalho S; Huntsman D; Gärtner F; Seruca R; Reis CA; Oliveira C
PLoS One; 2012; 7(3):e33191. PubMed ID: 22427986
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients.
Kohler RS; Anugraham M; López MN; Xiao C; Schoetzau A; Hettich T; Schlotterbeck G; Fedier A; Jacob F; Heinzelmann-Schwarz V
Oncotarget; 2016 Aug; 7(32):51674-51686. PubMed ID: 27429195
[TBL] [Abstract][Full Text] [Related]
5. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
6. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
Dan W; Li C; Li J; Li P; Xin M; Chen Z; Dang L; Yu Z; Li J; Shen J; Hu L; Sun S
Glycoconj J; 2022 Dec; 39(6):737-745. PubMed ID: 36322335
[TBL] [Abstract][Full Text] [Related]
8. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.
Song Y; Aglipay JA; Bernstein JD; Goswami S; Stanley P
Cancer Res; 2010 Apr; 70(8):3361-71. PubMed ID: 20395209
[TBL] [Abstract][Full Text] [Related]
9. Bisecting GlcNAc modification diminishes the pro-metastatic functions of small extracellular vesicles from breast cancer cells.
Tan Z; Cao L; Wu Y; Wang B; Song Z; Yang J; Cheng L; Yang X; Zhou X; Dai Z; Li X; Guan F
J Extracell Vesicles; 2020 Oct; 10(1):e12005. PubMed ID: 33304474
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
Stanley P; Sundaram S; Tang J; Shi S
Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
[TBL] [Abstract][Full Text] [Related]
11. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III.
Lee J; Park SH; Stanley P
Glycoconj J; 2002 Mar; 19(3):211-9. PubMed ID: 12815232
[TBL] [Abstract][Full Text] [Related]
12. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
13. Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell.
Li S; Mo C; Peng Q; Kang X; Sun C; Jiang K; Huang L; Lu Y; Sui J; Qin X; Liu Y
PLoS One; 2013; 8(8):e71273. PubMed ID: 23977005
[TBL] [Abstract][Full Text] [Related]
14. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.
Kizuka Y; Nakano M; Kitazume S; Saito T; Saido TC; Taniguchi N
Biochem J; 2016 Jan; 473(1):21-30. PubMed ID: 26467158
[TBL] [Abstract][Full Text] [Related]
15. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
16. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
[TBL] [Abstract][Full Text] [Related]
17. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
18. The bisecting GlcNAc in cell growth control and tumor progression.
Miwa HE; Song Y; Alvarez R; Cummings RD; Stanley P
Glycoconj J; 2012 Dec; 29(8-9):609-18. PubMed ID: 22476631
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.
Priatel JJ; Sarkar M; Schachter H; Marth JD
Glycobiology; 1997 Feb; 7(1):45-56. PubMed ID: 9061364
[TBL] [Abstract][Full Text] [Related]
20. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
